11.08.2022 16:18

Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions

Folgen
Werbung

NEW YORK, and LONDON, Aug. 11, 2022 /PRNewswire/ -- Huma Therapeutics Limited, a leading global digital health company, has appointed Kaushik Gune as the company's new U.S. Head of Healthcare. Gune joins Huma to drive further commercial adoption of the company's digital health platforms in the U.S., specifically its 'Care at Home' platform for remote patient monitoring.

Huma Logo


"Huma is transforming healthcare and research through its digital-first patient care platform, expanding access for patients, increasing capacity for clinical staff and delivering data insights for researchers and providers," said Gune. "I'm proud to be joining a team committed to transforming healthcare for all."

"Huma has established a strong track record working with more than 27 million patients across its platforms in the UK and across Europe - both in primary and secondary care," said Michael Macdonnell, SVP Healthcare and Global Head of Operations, Huma Therapeutics. "On the back of Huma's digital health partnership with AstraZeneca, as well as the coveted Prix Galien award, we are now taking our mission to provide digital-first care and research to the US market. Kaushik is the perfect leader for our expansion, combining strategic insight with the business know-how needed to bring our remote monitoring technology to millions of Americans."

Gune has held numerous senior leadership roles during his career with a focus on developing and advancing commercial products in the digital health market, most recently as VP of Digital Health & New Ventures at Smith+Nephew. Previously, he served as Chief Strategy & Business Development Officer at Innovative Health Diagnostics, where he led a diagnostic lab through a major growth phase managing finance, strategy and business development functions.

From a career spanning a range of business functions, Gune brings experience from Operations at United Airlines, Strategy & Commercial at McKinsey & Co and Finance at NuVasive. He holds a B.E. in Mechanical Engineering from University of Mumbai, an M.S. in Industrial Engineering from Purdue University and an M.B.A. in Strategy & Finance from INSEAD.

About Huma

Huma Therapeutics is a global digital health company headquartered in the UK that advances digital-first care delivery and research to help people live longer, fuller lives. Huma's award-winning modular platforms are used by more than 3,000 hospitals and clinics, with 1.8 million active users. Huma's offering works across different disease areas and powers:

-  'Hospitals at Home'
-  Software as a Medical Device (SaMD) solutions
-  DCT platform to support digital or hybrid studies

Huma's platform has been shown to almost double clinical capacity, reduce readmissions by over a third, enable better diversity, participant retention and protocol adherence, whilst allowing trials to run within weeks. Please visit www.huma.com and follow us on LinkedIn at Huma

Logo - https://mma.prnewswire.com/media/1427908/Huma_Logo.jpg

 

Cision View original content:https://www.prnewswire.com/news-releases/huma-appoints-kaushik-gune-as-head-of-us-healthcare-business-to-promote-adoption-of-digital-health-solutions-301604386.html

SOURCE Huma

JETZT LIVE: Platzt die Immobilienblase?

Grundbesitz gilt als krisensicher, doch manche Experten sehen bereits das Platzen der Immobilienblase voraus. Wie groß ist die Gefahr wirklich? Sollten Sie noch in Immobilien investieren? Und wie sichern Sie Ihr Eigenheim finanziell am besten ab?

Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Nach Stimmungsdaten: DAX schließt mit Verlusten -- Neue Sanktionen gegen Russland auf dem Weg -- Shop Apotheke erreicht wohl Gewinnschwelle -- Twitter, Lufthansa, Apple im Fokus

Siemens Gamesa wechselt Onshore-Chef aus. BKA geht anscheinend von staatlicher Sabotage bei Nord-Stream-Pipeline aus. Swift arbeitet an Vernetzung von digitalem Zentralbankgeld. Erdgaspreise sinken deutlich - Russlands GAZPROM beliefert Italien wieder mit Gas. Heidelberg Materials übernimmt JEV Recycling.

Umfrage

Glauben Sie, dass es in den kommenden sechs Monaten schwieriger wird, die eigenen Renditeerwartungen zu erzielen?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln